TRF2 interaction with nuclear envelope is required for cell polarization and metastasis in triple negative breast cancer.

Saved in:
Bibliographic Details
Title: TRF2 interaction with nuclear envelope is required for cell polarization and metastasis in triple negative breast cancer.
Authors: Petti E; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Di Vito S; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.; Department of Ecological and Biological Sciences (DEB), University of Tuscia, Viterbo, Italy., Dinami R; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Porru M; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Marchesi S; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy., Lohuis J; Division of Molecular Pathology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, the Netherlands., Zizza P; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Iachettini S; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Salvati E; Institute of Molecular Biology and Pathology, National Research Council, Rome, Italy., D'Angelo C; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Rizzo A; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Maresca C; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Ascione F; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy., Di Benedetto A; Department of Pathology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Buglioni S; Department of Pathology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Sacconi A; UOSD Clinical Trial Center, Biostatistics and Bioinformatics, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Ostano P; Cancer Genomics Lab, Fondazione Edo ed Elvo Tempia, Biella, Italy., Li Q; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy., Stoppacciaro A; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy., Leonetti C; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., van Rheenen J; Division of Molecular Pathology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, the Netherlands., Maiuri P; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.; Department of Molecular Medicine and Medical Biotechnology, Università degli Studi di Napoli 'Federico II', Naples, Italy., Scita G; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy., Biroccio A; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy. annamaria.biroccio@ifo.it.
Source: Cell death & disease [Cell Death Dis] 2025 Mar 30; Vol. 16 (1), pp. 224. Date of Electronic Publication: 2025 Mar 30.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40159489
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: TRF2 interaction with nuclear envelope is required for cell polarization and metastasis in triple negative breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Petti+E%22">Petti E</searchLink>; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Di+Vito+S%22">Di Vito S</searchLink>; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.; Department of Ecological and Biological Sciences (DEB), University of Tuscia, Viterbo, Italy.<br /><searchLink fieldCode="AU" term="%22Dinami+R%22">Dinami R</searchLink>; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Porru+M%22">Porru M</searchLink>; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Marchesi+S%22">Marchesi S</searchLink>; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Lohuis+J%22">Lohuis J</searchLink>; Division of Molecular Pathology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Zizza+P%22">Zizza P</searchLink>; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Iachettini+S%22">Iachettini S</searchLink>; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Salvati+E%22">Salvati E</searchLink>; Institute of Molecular Biology and Pathology, National Research Council, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22D'Angelo+C%22">D'Angelo C</searchLink>; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Rizzo+A%22">Rizzo A</searchLink>; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Maresca+C%22">Maresca C</searchLink>; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Ascione+F%22">Ascione F</searchLink>; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Di+Benedetto+A%22">Di Benedetto A</searchLink>; Department of Pathology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Buglioni+S%22">Buglioni S</searchLink>; Department of Pathology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Sacconi+A%22">Sacconi A</searchLink>; UOSD Clinical Trial Center, Biostatistics and Bioinformatics, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Ostano+P%22">Ostano P</searchLink>; Cancer Genomics Lab, Fondazione Edo ed Elvo Tempia, Biella, Italy.<br /><searchLink fieldCode="AU" term="%22Li+Q%22">Li Q</searchLink>; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Stoppacciaro+A%22">Stoppacciaro A</searchLink>; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Leonetti+C%22">Leonetti C</searchLink>; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22van+Rheenen+J%22">van Rheenen J</searchLink>; Division of Molecular Pathology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Maiuri+P%22">Maiuri P</searchLink>; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.; Department of Molecular Medicine and Medical Biotechnology, Università degli Studi di Napoli 'Federico II', Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Scita+G%22">Scita G</searchLink>; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Biroccio+A%22">Biroccio A</searchLink>; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy. annamaria.biroccio@ifo.it.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101524092%22">Cell death & disease</searchLink> [Cell Death Dis] 2025 Mar 30; Vol. 16 (1), pp. 224. <i>Date of Electronic Publication: </i>2025 Mar 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101524092 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-4889 (Electronic) <i>NLM ISO Abbreviation: </i>Cell Death Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40159489
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41419-025-07415-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 224
    Titles:
      – TitleFull: TRF2 interaction with nuclear envelope is required for cell polarization and metastasis in triple negative breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Petti E
      – PersonEntity:
          Name:
            NameFull: Di Vito S
      – PersonEntity:
          Name:
            NameFull: Dinami R
      – PersonEntity:
          Name:
            NameFull: Porru M
      – PersonEntity:
          Name:
            NameFull: Marchesi S
      – PersonEntity:
          Name:
            NameFull: Lohuis J
      – PersonEntity:
          Name:
            NameFull: Zizza P
      – PersonEntity:
          Name:
            NameFull: Iachettini S
      – PersonEntity:
          Name:
            NameFull: Salvati E
      – PersonEntity:
          Name:
            NameFull: D'Angelo C
      – PersonEntity:
          Name:
            NameFull: Rizzo A
      – PersonEntity:
          Name:
            NameFull: Maresca C
      – PersonEntity:
          Name:
            NameFull: Ascione F
      – PersonEntity:
          Name:
            NameFull: Di Benedetto A
      – PersonEntity:
          Name:
            NameFull: Buglioni S
      – PersonEntity:
          Name:
            NameFull: Sacconi A
      – PersonEntity:
          Name:
            NameFull: Ostano P
      – PersonEntity:
          Name:
            NameFull: Li Q
      – PersonEntity:
          Name:
            NameFull: Stoppacciaro A
      – PersonEntity:
          Name:
            NameFull: Leonetti C
      – PersonEntity:
          Name:
            NameFull: van Rheenen J
      – PersonEntity:
          Name:
            NameFull: Maiuri P
      – PersonEntity:
          Name:
            NameFull: Scita G
      – PersonEntity:
          Name:
            NameFull: Biroccio A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 03
              Text: 2025 Mar 30
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2041-4889
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cell death & disease
              Type: main
ResultId 1